Aprazer Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 Cr
as on 17-11-2024
- Satisfied Charges ₹ 5.00 Cr
as on 17-11-2024
- Revenue -4.56%
(FY 2023)
- Profit 28.58%
(FY 2023)
- Ebitda 16.10%
(FY 2023)
- Net Worth 80.59%
(FY 2023)
- Total Assets 23.58%
(FY 2023)
About Aprazer Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.00 Cr. The company has closed loans amounting to ₹5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Simranjit Gandhi and Rakesh Pandit serve as directors at the Company.
- CIN/LLPIN
U51909DL2017PTC326040
- Company No.
326040
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Nov 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aprazer Healthcare Private Limited offer?
Aprazer Healthcare Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antiviral Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Cardiovascular Drugs & Medication, Immunosuppressive Drugs, Sexual Wellness Products, Erectile Dysfunction Medicine, Antibacterial Drugs, Malaria Medicine.
Who are the key members and board of directors at Aprazer Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Simranjit Gandhi  | Director | 15-Nov-2017 | Current |
| Rakesh Pandit | Whole-Time Director | 29-Sep-2020 | Current |
Financial Performance of Aprazer Healthcare.
Aprazer Healthcare Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.56% decrease. The company also saw a substantial improvement in profitability, with a 28.58% increase in profit. The company's net worth Soared by an impressive increase of 80.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aprazer Healthcare?
In 2023, Aprazer Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Sep 2022 | ₹4.00 Cr | Open |
Others Creation Date: 08 May 2019 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Aprazer Healthcare?
Aprazer Healthcare has a workforce of 20 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aprazer Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aprazer Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
